Legend Biotech Corporation(LEGN)

Description: Legend Biotech Corporation develops cell therapy solutions for cancer patients. The company was founded in 2014 and is based in Cayman Islands. The company operates as a subsidiary of Genscript Biotech Corporation.

Keywords: Cancer Life Sciences Cell Therapy Tax Investigation Genscript Biotech Sartorius Ag Spotlight Innovation

Home Page:

LEGN Technical Analysis

2101 Cottontail Lane
Somerset, NJ 08873
United States
Phone: 732 317 5050


Name Title
Dr. Ying Huang Ph.D. CEO & Director
Ms. Lori A. Macomber CPA Chief Financial Officer
Joanne Choi Sr. Mang. of Investor Relations
Mr. Marc Harrison VP & Gen. Counsel
Deborah Wong Exec. Director of Strategic Marketing & Corp. Communications
Ms. Liz Gosen Sr. VP of Global Technical Operations
Dr. Yuhong Qiu Ph.D. Sr. VP of Global Regulatory Affairs
Dr. Guowei Fang Ph.D. Sr. VP & Global Head of Research and Early Devel.
Mr. Steven J. Gavel Sr. VP of Commercial Devel., US & Europe
Mr. Alan Kick Sr. VP of Global Quality

Exchange: NASDAQ

Country: US

Currency: US Dollar ($)

Forward PE: 0
Trailing PE: 0
Price-to-Book MRQ: 19.803
Price-to-Sales TTM: 73.1773
IPO Date: 2020-06-05
Fiscal Year End: December
Full Time Employees: 1071
Back to stocks